Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-11-29

Clinical Trial Update: Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and tolerability of a topical microemulsion for allergic rhinitis caused by pollen sensitization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical microemulsion

Snippet

Sponsor: Reig Jofre Group | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED